Protein Production Technology Podcast

FPG Media

Helping the industry understand how it will revolutionize modern protein production and help build a healthier, more efficient, and sustainable global protein system

  1. 2d ago

    Episode 39: IP as a Growth Engine: Unlocking Investment in Food Tech In Partnership with HGF

    Powered by Protein Production Technology InternationalA breakthrough ingredient or production process may create headlines, but can it create a defensible business? In this episode of the Protein Production Technology International podcast, Nick Bradley was joined by Kerry Rees and Andrew Tindall of HGF, alongside Gilbert Verschelling of The Protein Brewery, Tim Fronzek of Nosh.bio, and Casey Lippmeier of Checkerspot, to explore how alternative protein companies can build intellectual property strategies that support long-term commercial success. The panel discussed why effective IP management extends far beyond filing patents, examining how founders can align protection strategies with business objectives, fundraising plans, partnerships, and commercialization roadmaps. The conversation explored the balance between patents and trade secrets, the risks of over-filing, and how companies can ensure their most valuable innovations remain protected as they scale. The speakers also shared insights into what investors look for when assessing technology businesses, explaining why strong IP portfolios can strengthen a company's position but are rarely enough on their own. Market traction, execution capability, regulatory progress, and commercial readiness all play critical roles in building investor confidence. From collaboration agreements and freedom-to-operate considerations to licensing strategies and enforcement, the discussion offered practical guidance for founders navigating one of the most important - and often misunderstood - aspects of building an alternative protein company. A must-listen for founders, R&D leaders, investors, legal teams, and anyone seeking to transform innovation into a scalable and defensible business.

    Episode 39: IP as a Growth Engine: Unlocking Investment in Food Tech In Partnership with HGF
  2. Jul 22

    Special Episode: John Krzywicki - Checkerspot

    Powered by Protein Production Technology InternationalWhat does it take for a biotechnology company to evolve from a promising startup into a commercially focused nutrition business? In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with John Krzywicki, CEO of Checkerspot, to discuss the company's journey from developing industrial materials to commercializing high-value nutritional ingredients derived from microalgae. Krzywicki shared how Checkerspot is using heterotrophic microalgae and precision fermentation to produce specialty fats and oils, including ingredients designed to replicate those found naturally in human breast milk. The conversation explored why microalgae offers unique advantages as a production platform and how advances in biotechnology are opening new opportunities in infant nutrition and broader health applications. The discussion also provided a candid look at the realities of scale-up, including resource allocation, capital efficiency, and the strategic decisions required to focus on the most commercially attractive opportunities. Krzywicki explained why partnerships have played a critical role in the company's growth and how Checkerspot's licensing-led approach is designed to accelerate adoption while minimizing capital requirements. From ingredient innovation and commercialization to manufacturing strategy and market focus, the episode highlighted the challenges and opportunities facing biotechnology companies as they transition from technology development to sustainable business growth. A must-listen for fermentation companies, ingredient developers, nutrition brands, investors, and anyone interested in the commercialization of next-generation food ingredients.

    Special Episode: John Krzywicki - Checkerspot
  3. Jul 15

    Special Episode: Thomas G Schmidt - 21st BIO

    Powered by Protein Production Technology InternationalWhy do so many promising biotechnology breakthroughs fail to reach commercial scale? In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with Thomas G. Schmidt, CEO of 21st.BIO, to discuss one of the industry's biggest challenges: bridging the 'Valley of Death' between laboratory success and industrial-scale production. Drawing on the company's roots within the Novo Group ecosystem, Schmidt explained how 21st.BIO is helping startups accelerate commercialization by providing access to proven technology platforms, industrial expertise, and large-scale production capabilities. The conversation explored why scientific innovation alone is rarely enough and why companies must demonstrate credible pathways to manufacturing at scale. Schmidt also shared his perspective on the future economics of precision fermentation, including why achieving competitive production costs, improving titers, and maximizing carbon conversion efficiency will be critical to long-term success. The discussion examined 21st.BIO's work with beta-lactoglobulin (BLG), the importance of moving beyond sustainability-focused narratives, and the need to build businesses that can compete on performance and economics. The episode also looked at how biotechnology can evolve from replicating existing proteins to creating entirely new nutritional possibilities, unlocking greater efficiency and helping meet growing global demand for protein. From scale-up and manufacturing to investment, partnerships, and the future of precision fermentation, this conversation offered valuable insights into what it will take to transform breakthrough science into commercially viable food production. A must-listen for fermentation companies, investors, food manufacturers, technology developers, and anyone interested in the realities of scaling the next generation of protein production.

    Special Episode: Thomas G Schmidt - 21st BIO
  4. Jul 8

    Special Episode: Yvan Chardonnens - STANDING OVATION

    Powered by Protein Production Technology InternationalCan dairy proteins be produced without cows while still delivering the taste, texture, and functionality consumers expect? In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with Yvan Chardonnens, CEO of Standing Ovation, to discuss how precision fermentation is being used to produce animal-free casein and what that could mean for the future of dairy. Chardonnens explained why casein remains one of the most challenging and important dairy proteins to replicate, particularly for applications such as cheese, where melt, stretch, and texture are critical. The conversation explored Standing Ovation's approach to producing casein through fermentation, as well as the company's broader ambition to help address growing global protein demand. A key focus of the discussion was Standing Ovation's circular economy model, which utilizes dairy industry side streams such as acid whey as fermentation feedstocks. Chardonnens shared how this approach can reduce production costs while creating new value streams for dairy processors, demonstrating how traditional and emerging food technologies can work together. The episode also examined partnerships with major dairy companies, progress toward regulatory approval in the USA, and the potential role of hybrid dairy products in introducing fermentation-derived proteins to consumers. From food sovereignty and sustainability to commercialization and consumer acceptance, this conversation offered a detailed look at how precision fermentation could help reshape the future of dairy production. A must-listen for dairy companies, food manufacturers, fermentation innovators, investors, and anyone interested in the next generation of functional proteins.

    Special Episode: Yvan Chardonnens - STANDING OVATION
  5. Jul 1

    Special Episode: Joshua Errett - Friends & Family

    Powered by Protein Production Technology InternationalWhat if cultivated meat's first commercial breakthrough comes through pet food rather than human food? In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with Joshua Errett, Founder and CEO of Friends & Family Pet Food Company, to discuss the launch of cultivated pet food in Singapore and why he believes the category could become one of the most important early markets for cultivated proteins. Drawing on more than a decade in the alternative protein sector, Errett shared his perspective on the industry's evolution and explained why he views cultivated meat as an entirely new ingredient platform rather than simply an alternative to conventional meat. The conversation explored changing consumer expectations around pet nutrition, the growing shift away from highly processed kibble, and the opportunity to deliver fresher, higher-quality ingredients for companion animals. Errett also discussed the limitations of traditional rendering processes, the importance of preserving protein quality and essential amino acids, and why communicating clear nutritional benefits matters more than focusing on the technical details behind production. From commercialization and consumer acceptance to sustainability and animal health, the discussion offered a fascinating look at how cultivated proteins could reshape one of the world's largest and fastest-growing pet food markets. A must-listen for pet food manufacturers, cultivated meat companies, investors, and anyone interested in where alternative proteins may achieve their next major commercial milestone.

    Special Episode: Joshua Errett - Friends & Family

About

Helping the industry understand how it will revolutionize modern protein production and help build a healthier, more efficient, and sustainable global protein system